Concepedia

UC Broedl

UB

Statistics

Publications

3

Citations

76

H-Index

3

Active since

2014

Affiliations

Boehringer Ingelheim (Germany)(Current)

University of Rochester

UC Broedl is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacotherapy, and diabetes.

Top concepts

Publications per year

2014–2016

3

Publications

3

Empagliflozin improves glycemic parameters and cardiovascular risk factors in patients with Type 2 Diabetes (T2DM): Pooled data from four pivotal phase III trials

Thomas Hach, John E. Gerich, Afshin Salsali et al. · Diabetologie und Stoffwechsel · 2014 · 41 citations

, , +19

Empagliflozin (EMPA) increases genital infections but not Urinary Tract Infections (UTIs) in pooled data from four pivotal phase III trials

G Kim, J. E. Gerich, Afshin Salsali et al. · Diabetologie und Stoffwechsel · 2014 · 21 citations

, , +17

Safety and tolerability of empagliflozin in patients with type 2 diabetes

Sven Köhler, Afshin Salsali, Stefan Hantel et al. · Diabetologie und Stoffwechsel · 2016 · 14 citations

1–3 of 3